Clinical Trials
4 trialsNCT05948943 2026-05-12
EPIK-L1
Novartis
Phase 2/3 Recruiting
NCT05983159 2026-05-05
TARGET-VM
Murdoch Childrens Research Institute
Phase 2 Recruiting
NCT06239480 2026-03-27
SELVA
Palvella Therapeutics, Inc.
Phase 3 Active not recruiting
NCT07477548 2026-03-17
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Yonsei University
Phase 2 Not yet recruiting